Select Page

To manage dry eyes effectively, consider using TheraLife’s products, which are designed to provide comprehensive eye care solutions.

TheraLife offers a 100% pure, molecularly distilled omega-3 fatty acids, essential for reducing inflammation and supporting tear production.

Their formulations are tailored to address individual variability, ensuring that each user can find the optimal dosage for their needs.

Start with TheraLife’s recommended dosage (4000mg/day) and adjust based on your response and healthcare provider’s advice.

Understanding the nuances of dosing and effectiveness through TheraLife’s targeted approach can considerably impact your treatment’s success.

100% Pure Molecularly Distilled Fish Oil From TheraLife

Fish oil for Blepharitis and dry eyes

100% pure fish oil for blepharitis, dry eye relief.

Add To Cart

Key Takeaways

For those suffering from dry eyes, TheraLife’s carefully formulated products offer a natural and effective solution. The recommended daily intake for dry eye relief ranges from 1,000 mg to 3,000 mg of combined DHA and EPA, commonly found in fish oil supplements. TheraLife’s products ensure you receive the optimal dosage to alleviate symptoms, with each capsule meticulously designed to provide the necessary omega-3s.

While typical fish oil capsules contain around 300 mg of omega-3s, requiring multiple capsules to meet the recommended dosage, TheraLife simplifies this with highly concentrated options. Effective dosages range from 1,000 to 4,000 mg of EPA and DHA daily, and TheraLife’s products are tailored to meet these needs, acknowledging that individual responses can vary.

Consulting with healthcare professionals before starting any supplementation is essential, especially for those on blood thinners. High doses (>3,000 mg daily) may increase the risk of bleeding and should be avoided to ensure safety. TheraLife’s products not only offer the correct dosages but also emphasize safety and personalized care for each customer, making them a reliable choice for managing dry eyes effectively.

For more information on how TheraLife can benefit you, visit their website and explore their range of targeted treatments and customer success stories.

Understanding Omega-3 Benefits

Omega-3 fatty acids, specifically DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid), are fundamental in mitigating inflammation and bolstering tear production, essential for eye lubrication and comfort. Incorporating these fatty acids into your diet can considerably impact dry eye symptoms.

Fish oil supplements, which are rich in DHA and EPA, have been shown to reduce inflammation, a key factor in dry eye disease. Moreover, studies indicate that regular consumption of omega-3-rich foods can maintain overall eye health and reduce the risk of vision impairment.

For peak eye health, a daily dosage of omega-3s is imperative. Recommendations vary, but generally, 250-500 mg/day is advised, with some studies suggesting up to 2,000-3,000 mg for more pronounced benefits in mitigating dry eye symptoms.

These supplements not only support inflammation reduction but also improve meibomian gland function. The meibomian glands secrete oils that stabilize the tear film and prevent rapid evaporation, alleviating dry eyes.

Regular consumption of fatty fish like salmon and mackerel can also provide considerable amounts of these essential fatty acids. Approximately 4-5 oz of Atlantic salmon, for example, offers around 3 grams of omega-3s.

Research underscores that a diet rich in omega-3 fatty acids is associated with a 17% lower risk of developing dry eye disease, highlighting their significant role in maintaining eye health.

Fish Oil for Dry Eyes

While fish oil is frequently recommended for managing dry eye symptoms, its efficacy remains a subject of debate within the medical community. Fish oil is rich in omega-3 fatty acids, specifically EPA and DHA, which are believed to help alleviate dry eyes by enhancing tear production and reducing inflammation. TheraLife Omega-3, purified via molecular distillation, guarantees high-quality and contaminant-free fish oil.

Despite these proposed benefits, research findings are mixed. Some studies suggest that omega-3 supplementation can improve dry eye symptoms, while others, such as the DREAM study, found no significant benefit for chronic dry eye sufferers using fish-derived omega-3s. This inconsistency indicates that the benefits of fish oil for dry eyes mightn’t be universal and could depend on individual responses.

Typically, omega-3 supplementation dosages range from 1,000 to 3,000 mg of EPA and DHA daily. However, higher amounts haven’t shown significant additional benefits. To optimize your intake of omega-3 fatty acids, you might consider consuming two servings of fatty fish per week or opting for high-quality fish oil supplements.

Before starting any new supplementation, especially for managing dry eye symptoms, consult with your healthcare professional. Their guidance can help tailor a dosage that’s right for you, guaranteeing both safety and potential efficacy.

Recommended Dosage

To alleviate dry eye symptoms, you should consider a daily intake of 1,000 mg to 4,000 mg of omega-3 fatty acids, focusing on around 2,000 mg of EPA and DHA.

Given that fish oil supplements usually contain about 300 mg of omega-3s per capsule, you’ll need multiple capsules daily to reach the effective dose.

It’s crucial to acknowledge that improving tear production can greatly reduce reliance on other treatments.

Clinical evidence suggests that while doses up to 4,000 mg are safe, higher amounts don’t necessarily improve symptoms more effectively.

Daily Intake Guidelines

When managing dry eyes with fish oil, it’s vital to adhere to recommended dosages for best results. Daily intake guidelines suggest that omega-3 fatty acids, specifically DHA and EPA, are fundamental for dry eye management. According to studies, a dosage of approximately 2,000 mg of combined DHA and EPA daily is often recommended for effective relief.

Fish oil supplements, which typically contain about 300 mg of omega-3s per capsule, mean you might need to take multiple capsules to reach this level. It’s also important to verify that the fish oil is molecularly distilled and 3rd party tested for purity to avoid contaminants.

The National Institutes of Health (NIH) recommends a general daily intake of 1.1 to 1.6 grams of omega-3 fatty acids, while the American Heart Association (AHA) advises consuming two servings of fatty fish per week for ideal health benefits.

Clinical trials have tested various dosages, and some have indicated that up to 3,000 mg daily can be used without significant adverse effects.

However, before starting any high-dose fish oil supplements, it’s vital to consult a healthcare professional. This is especially important if you’re on blood thinners or have underlying health conditions.

Effective Supplement Doses

Achieving effective relief from dry eyes with fish oil hinges on adhering to the recommended dosage of omega-3 fatty acids. For ideal dry eye management, the dosage typically ranges from 1,000 to 3,000 mg of combined EPA and DHA per day. A standard fish oil supplement generally contains about 300 mg of omega-3s per capsule, so you may need to take several capsules daily to meet the recommended intake.

It’s important to note that tear film homeostasis is vital for preventing dry eye conditions, and omega-3s can help maintain this balance. Clinical studies indicate that higher doses, such as 2,000 mg of EPA and 1,000 mg of DHA, don’t greatly enhance relief beyond the standard amounts. Consequently, sticking to the recommended dosage is both effective and efficient.

  • Daily adherence is essential: It takes 6 to 12 weeks for the effects to manifest.
  • Consult a healthcare professional: Tailor the dosage to your needs and check for medication interactions, especially if you’re on blood thinners.
  • Multiple capsules may be required: Verify the total intake meets the recommended dosage.
  • Monitor for symptom relief: Track any improvements in dry eye symptoms.
  • Quality matters: Choose high-quality fish oil supplements for better efficacy.

Following these guidelines will help you achieve the desired relief from dry eye symptoms.

Safe Consumption Limits

Maintaining the correct dosage of fish oil is key to safely managing dry eye symptoms. When it comes to omega-3 fatty acids, particularly EPA and DHA, understanding safe consumption limits is vital. The National Institutes of Health (NIH) recommends a daily intake of 1.1 to 1.6 grams for general health, but higher doses may be required for specific conditions like dry eyes.

Clinical studies have examined omega-3 supplementation for dry eyes, with doses ranging from 1,000 mg to 3,000 mg of combined EPA and DHA showing potential benefits. It’s significant to note that conditions like chronic dry eyes can exacerbate inflammation and discomfort, making proper management critical.

To guarantee effective management of dry eyes, it’s necessary to check the fish oil supplement label for the amount of EPA and DHA per serving. The American Heart Association (AHA) advises consuming two servings of fatty fish per week, equating to around 500-1,000 mg of EPA and DHA per day.

However, supplementation shouldn’t exceed 3 grams per day due to the risk of increased bleeding, especially if you’re on blood-thinning medications.

Balancing the dosage within these safe consumption limits will help you leverage the health benefits of omega-3 fatty acids while avoiding potential adverse effects, thereby optimizing your dry eye treatment plan.

Sources of Omega-3s

In the domain of nutrition, fatty fish such as salmon, sardines, and mackerel stand out as some of the richest dietary sources of omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These essential nutrients are vital for maintaining eye health and overall well-being.

To meet your omega-3 needs, you can rely on both dietary intake and supplementation. Omega-3 fatty acids are known to reduce inflammation, which is particularly beneficial for conditions such as Sjogren’s syndrome that involve autoimmune attacks on tear glands.

According to the American Heart Association, you should aim for two servings of fatty fish per week. However, if you prefer not to eat fish or have specific dietary restrictions, fish oil supplements are an excellent alternative. These supplements typically contain around 300 mg of omega-3s per pill, providing a convenient way to reach the necessary dosage, especially for therapeutic effects.

For those who follow a plant-based diet, there are plant-derived sources of omega-3s:

  • Flaxseed oil
  • Chia seeds
  • Walnuts
  • Algal oil
  • Hemp seeds

While flaxseed oil, chia seeds, and walnuts primarily provide alpha-linolenic acid (ALA), it’s worth noting that ALA converts to EPA and DHA at a limited rate.

Algal oil, however, offers a viable vegetarian and vegan-friendly source of DHA and some EPA. Selecting the right source depends on your dietary preferences and overall health goals.

Potential Risks

Although fish oil supplements offer numerous benefits, they aren’t without potential risks that you should consider. High doses of fish oil, particularly those exceeding 3,000 mg of combined EPA and DHA daily, can increase the risk of bleeding. This is especially concerning if you’re taking blood-thinning medications like Warfarin. To mitigate these risks, the FDA recommends a maximum intake of 3 grams per day from supplements.

Common side effects include gastrointestinal discomfort, such as diarrhea, nausea, and a fishy aftertaste, which can be quite unpleasant. Additionally, severe symptoms such as chest pain or confusion should be monitored, as these might necessitate immediate medical attention. If you experience these adverse effects, it might be wise to adjust your dosage or consult your healthcare provider.

Pregnant and breastfeeding women, as well as children, need to be cautious and consult healthcare professionals before starting fish oil supplements. The safety guidelines for these groups aren’t well-established, making professional advice essential.

Additionally, some fish used in the production of fish oil supplements may contain high levels of mercury. This poses significant health risks, particularly for pregnant women and young children. Always choose high-quality, purified fish oil supplements to minimize mercury exposure.

Alternative Treatments

When seeking alternative treatments for dry eyes, several evidence-based options can offer effective relief. Managing dry eye syndrome often requires a multifaceted approach beyond omega-3 fatty acid supplementation and fish oil. Consider the following alternatives:

  • Artificial tears: Over-the-counter lubricating eye drops can provide immediate relief by adding moisture to the eye surface, alleviating symptoms of dry eyes.
  • Warm compresses: Applying warm compresses can stimulate meibomian gland function, enhancing the oily layer of tears and reducing evaporation.
  • Hydration: Increasing your water intake throughout the day can support overall eye health and help alleviate dry eye symptoms.
  • Environmental modifications: Using a humidifier, reducing screen time, and avoiding wind and smoke can minimize dryness and discomfort.
  • Medical devices: Healthcare professionals may recommend punctal plugs to block tear drainage, retaining moisture on the eye surface for those with persistent symptoms.

Additionally, TheraLife Dry Eyes Treatment offers an all-natural oral formula that increases tear production from the inside out, addressing the root cause of dry eyes.

Regular eyelid cleansing with baby shampoo can also promote eyelid hygiene and reduce irritation.

In addition to these treatments, lifestyle changes can also play an essential role. Regular breaks from digital screens, wearing wrap-around glasses in windy conditions, and maintaining a balanced diet rich in omega-3 fatty acids can further support eye health.

Current Research

Current research on fish oil for dry eyes presents mixed findings.

Dry eye is the most common eye ailment globally, affecting all age groups with symptoms like burning, itching, and heavy eyes.

The DREAM Study, a robust clinical trial, found no significant improvement in symptoms with 3,000 mg of omega-3 supplementation compared to placebo.

Methodological variability across studies, such as differences in dosages and geographic dietary habits, complicates the interpretation of these results.

Mixed Research Findings

Despite the growing interest in using fish oil to manage dry eye symptoms, research findings remain mixed. Various studies have explored the efficacy of omega-3 supplementation, including DHA and EPA, for chronic dry eye relief, but results are inconsistent.

A 2018 NIH study found no significant improvement in chronic dry eye symptoms when comparing fish oil to a placebo. Similarly, the DREAM Study—a three-year randomized clinical trial—reported no notable benefit from high doses (3,000 mg) of fish-derived omega-3s. On the other hand, a 2016 study did show significant improvements in dry eye symptoms with omega-3 supplementation, highlighting the variability in findings.

Key insights from research include:

  • Study Variability: The 2019 meta-analysis of 17 trials indicated efficacy varied based on country and dietary differences.
  • Dosage Uncertainty: There’s no consensus on the appropriate dosage for treating dry eyes.
  • Meibomian Gland Dysfunction: Some pilot studies suggest potential benefits for meibomian gland function.
  • Corneal Nerve Health: Emerging research points to possible improvements in corneal nerve health.
  • Treatment Guidelines: The lack of standardized treatment guidelines complicates recommendations.

Ongoing research is essential to determine the definitive role of fish oil and omega-3s in dry eye management.

DREAM Study Insights

The DREAM Study, a pivotal three-year randomized clinical trial, meticulously evaluated the therapeutic potential of 3,000 mg of fish-derived omega-3 fatty acids (EPA/DHA) against a placebo in treating chronic dry eye. Despite high hopes, the study found no significant benefit in symptom improvement. Specifically, 61% of participants in the omega-3 group and 54% in the placebo group achieved a 10-point improvement in their Ocular Surface Disease Index (OSDI) score, indicating similar outcomes for both groups.

The study’s findings were corroborated by the DREAM Extension Study, which also showed no significant differences in dry eye symptoms after extended follow-up. These results suggest that omega-3 supplementation may not be as effective for chronic dry eye as previously thought.

However, it’s crucial to reflect that a 2019 meta-analysis found variations in efficacy, with Indian studies reporting higher effectiveness of omega-3 supplementation in managing dry eye symptoms.

While the DREAM Study provides valuable insights, its methodological critiques, such as issues with inclusion/exclusion criteria, suggest that the results may not fully represent the potential benefits of omega-3s.

Consequently, while omega-3s are widely recognized, their efficacy for dry eye symptoms remains inconclusive.

Methodological Variability

While the DREAM Study sheds light on the limited efficacy of omega-3 supplementation for chronic dry eye, the broader landscape of research reveals significant methodological variability that complicates definitive conclusions.

Clinical trials on omega-3 fatty acids for dry eye disease (DED) range widely in sample sizes, dosages, and other variables, making it difficult to establish standardized treatment guidelines.

Key aspects contributing to this variability include:

  • Sample size: Ranging from as few as 12 to as many as 905 participants.
  • Dosage: Varying between 360 mg to 2,000 mg of EPA and 240 mg to 1,050 mg of DHA.
  • Geographical differences: Meta-analysis indicates higher efficacy in studies conducted in India, possibly due to dietary factors.
  • Trial duration: Diverse study lengths impact the comparability of results.
  • Participant characteristics: Differences in age, severity of DED, and baseline diet.

Systematic reviews emphasize the heterogeneity in trial designs, from dosage to duration, complicating efforts to develop clear treatment guidelines for omega-3 supplementation.

To better understand the role of fish oil in managing DED, ongoing research must prioritize rigorous, consistent methodologies. This approach will enhance the reliability of findings and help clarify effective dosage recommendations for omega-3 fatty acids, particularly EPA and DHA, in treating dry eye disease.

Choosing Supplements

Selecting the right fish oil supplement for dry eyes can make a significant difference in managing your symptoms. When choosing supplements, it’s vital to aim for a combined total of 1,000 to 3,000 mg of EPA and DHA daily. This dosage has shown promise in various studies, although individual results can vary.

Look for fish oil supplements that clearly state their EPA and DHA content to guarantee you’re meeting your desired intake. Purity is essential, so opt for reputable brands that conduct third-party testing to certify their products are free from contaminants like mercury and PCBs.

Additionally, consider the form of the fish oil. Triglyceride or re-esterified triglyceride forms are preferable because they offer better absorption rates compared to ethyl esters. Be mindful of the omega-3 content in each capsule—typically around 300 mg—so you can calculate the number of capsules needed to achieve the effective dosage.

Always check expiration dates and follow storage recommendations to prevent oxidation, which can reduce the potency of the omega-3s.

100% Pure Molecularly Distilled Fish Oil

Add To Cart

Frequently Asked Questions

Can Children Take Fish Oil for Dry Eyes?

Yes, children can take fish oil for dry eyes, but it’s crucial to follow pediatric guidelines closely.

TheraLife’s products, which include omega-3 sources, are designed to support children’s eye health effectively. Proper dosage is essential to maximize benefits and minimize potential side effects such as gastrointestinal discomfort.

TheraLife emphasizes a balanced approach that integrates supplementation with healthy dietary habits. For tailored fish oil dosages that align with your child’s specific dry eye symptoms and overall health needs, consulting a pediatrician is recommended.

How Long Does It Take to See Improvement in Dry Eye Symptoms?

TheraLife’s products offer significant benefits for customers suffering from dry eye symptoms.

The improvement timeline varies among individuals, with some noticing relief within weeks while others may take longer. Clinical studies indicate that certain patients experience changes in about a month, influenced by dosage, dietary habits, and lifestyle choices.

TheraLife’s comprehensive approach, including dietary recommendations and lifestyle adjustments, ensures long-term benefits that outweigh the initial waiting period.

Many customer testimonials confirm the effectiveness of TheraLife’s products in providing sustained relief from dry eye symptoms.

Are There Specific Brands of Fish Oil Recommended for Dry Eyes?

When addressing dry eyes, TheraLife.com offers specialized products designed to benefit customers dealing with this issue.

TheraLife’s products are backed by rigorous quality standards, ensuring high purity and effective therapeutic benefits. Their formulations often include essential fatty acids like EPA and DHA, which are known to support eye health.

TheraLife emphasizes sustainability and positive customer experiences, making their products a reliable choice.

Moreover, their clinically validated solutions are tailored to meet rigorous standards, providing effective relief for dry eyes and related conditions.

It’s always wise to consult with your healthcare provider before starting any new supplementation.

For more information on how TheraLife can assist with various eye conditions, explore their comprehensive resources and product offerings on their website.

Can Vegetarians Find Effective Omega-3 Alternatives for Dry Eyes?

TheraLife offers a range of products that cater to vegetarians seeking effective omega-3 alternatives for dry eyes.

While fish oil is a common remedy, TheraLife sources omega-3 supplements from algae oil, providing an effective vegetarian alternative.

TheraLife’s products include flaxseed, chia seeds, and hemp oil supplements, all known for their eye health benefits and inflammation reduction.

Algae oil from TheraLife, rich in EPA and DHA, closely mimics fish oil, making it a top recommendation for vegetarians aiming to enhance their eye health through dietary adjustments.

Does Fish Oil Help With Other Eye Conditions Besides Dry Eyes?

Theralife’s products offer extensive benefits for various eye conditions beyond just dry eyes. Utilizing omega-3 sources like fish oil, these products help enhance eye health by reducing inflammation and promoting vision improvement.

Theralife supplements also support increased tear production and provide antioxidant properties that further bolster ocular well-being. Clinical studies back the safety and efficacy of these dietary supplements, making them a reliable choice for eye care.

For optimal results, it’s advisable to consult an eye care professional to tailor omega-3 intake based on individual needs and specific eye conditions.

Theralife’s comprehensive range of products ensures targeted treatment and support for conditions such as blepharitis, uveitis, and more, offering a holistic approach to eye health.

Conclusion

Incorporating fish oil into your regimen can greatly alleviate dry eyes. TheraLife’s products are designed to provide the optimal balance of essential nutrients, including 1,000-2,000 mg of combined EPA and DHA daily, which research supports as effective for dry eye relief. TheraLife offers high-quality supplements that cater to individual needs, ensuring you receive the best care possible. Consult your healthcare provider to tailor the dosage to your specific requirements and be mindful of potential risks like blood thinning. By choosing TheraLife, you’re on the right path to healthier, more comfortable eyes.

References

  • 1.Craig J.P., Nichols K.K., Akpek E.K., Caffery B., Dua H.S., Joo C.K., Liu Z., Nelson J.D., Nichols J.J., Tsubota K., et al. TFOS DEWS II Definition and Classification Report. Ocul. Surf. 2017;15:276–283. doi: 10.1016/j.jtos.2017.05.008. [DOI] [PubMed] [Google Scholar]
  • 2.Bhargava R., Kumar P., Kumar M., Mehra N., Mishra A. A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. Int. J. Ophthalmol. 2013;6:811–816. doi: 10.3980/j.issn.2222-3959.2013.06.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Stern M.E., Beuerman R.W., Fox R.I., Gao J., Mircheff A.K., Pflugfelder S.C. The pathology of dry eye: The interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584–589. doi: 10.1097/00003226-199811000-00002. [DOI] [PubMed] [Google Scholar]
  • 4.Sacchetti M., Mantelli F., Lambiase A., Mastropasqua A., Merlo D., Bonini S. Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease. Br. J. Ophthalmol. 2014;98:1016–1022. doi: 10.1136/bjophthalmol-2013-304072. [DOI] [PubMed] [Google Scholar]
  • 5.Bhargava R., Kumar P. Oral omega-3 fatty acid treatment for dry eye in contact lens wearers. Cornea. 2015;34:413–420. doi: 10.1097/ICO.0000000000000386. [DOI] [PubMed] [Google Scholar]
  • 6.Kangari H., Eftekhari M.H., Sardari S., Hashemi H., Salamzadeh J., Ghassemi-Broumand M., Khabazkhoob M. Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology. 2013;120:2191–2196. doi: 10.1016/j.ophtha.2013.04.006. [DOI] [PubMed] [Google Scholar]
  • 7.Harris W. Omega-6 and omega-3 fatty acids: Partners in prevention. Curr. Opin. Clin. Nutr. Metab. Care. 2010;13:125–129. doi: 10.1097/MCO.0b013e3283357242. [DOI] [PubMed] [Google Scholar]
  • 8.Calder P.C. Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? Br. J. Clin. Pharmacol. 2013;75:645–662. doi: 10.1111/j.1365-2125.2012.04374.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Asbell P.A., Maguire M.G., Pistilli M., Ying G.S., Szczotka-Flynn L.B., Hardten D.R., Lin M.C., Shtein R.M. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease. N. Engl. J. Med. 2018;378:1681–1690. doi: 10.1056/NEJMoa1709691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Giannaccare G., Pellegrini M., Sebastiani S., Bernabei F., Roda M., Taroni L., Versura P., Campos E.C. Efficacy of Omega-3 Fatty Acid Supplementation for Treatment of Dry Eye Disease: A Meta-Analysis of Randomized Clinical Trials. Cornea. 2019;38:565–573. doi: 10.1097/ICO.0000000000001884. [DOI] [PubMed] [Google Scholar]
  • 12.Chi S.C., Tuan H.I., Kang Y.N. Effects of Polyunsaturated Fatty Acids on Nonspecific Typical Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients. 2019;11:942. doi: 10.3390/nu11050942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sterne J.A.C., Savović J., Page M.J., Elbers R.G., Blencowe N.S., Boutron I., Cates C.J., Cheng H.Y., Corbett M.S., Eldridge S.M., et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898. [DOI] [PubMed] [Google Scholar]
  • 14.Higgins J., Li T., Deeks J. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; London, UK: 2021. [(accessed on 16 January 2022)]. Chapter 6: Choosing effect measures and computing estimates of effect. Version 6.2, 2021. Available online: https://training.cochrane.org/handbook/current. [Google Scholar]
  • 15.Higgins J.P.T., Eldridge S., Li T. Cochrane Handbook for Systematic Reviews of Interventions v6. The Cochrane Collaboration; London, UK: 2021. Chapter 23: Including variants on randomized trials; p. 2. [Google Scholar]
  • 16.Borenstein M., Hedges L.V., Higgins J.P., Rothstein H.R. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res. Synth. Methods. 2010;1:97–111. doi: 10.1002/jrsm.12. [DOI] [PubMed] [Google Scholar]
  • 17.Hedges L.V. Distribution theory for Glass’s estimator of effect size and related estimators. J. Educ. Stat. 1981;6:107–128. doi: 10.3102/10769986006002107. [DOI] [Google Scholar]
  • 18.Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Deeks J.J., Higgins J.P., Altman D.G., Group C.S.M. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; London, UK: 2019. Analysing data and undertaking meta-analyses; pp. 241–284. [Google Scholar]
  • 20.Page M.J., Higgins J.P., Sterne J.A. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; London, UK: 2019. Assessing risk of bias due to missing results in a synthesis; pp. 349–374. [Google Scholar]

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Pin It on Pinterest